These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 15994344

  • 1. Stimulation of resorption in cultured mouse calvarial bones by thiazolidinediones.
    Schwab AM, Granholm S, Persson E, Wilkes B, Lerner UH, Conaway HH.
    Endocrinology; 2005 Oct; 146(10):4349-61. PubMed ID: 15994344
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway.
    Palmqvist P, Lundberg P, Persson E, Johansson A, Lundgren I, Lie A, Conaway HH, Lerner UH.
    J Biol Chem; 2006 Feb 03; 281(5):2414-29. PubMed ID: 16251181
    [Abstract] [Full Text] [Related]

  • 3. Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones.
    Swanson C, Lorentzon M, Conaway HH, Lerner UH.
    Endocrinology; 2006 Jul 03; 147(7):3613-22. PubMed ID: 16614077
    [Abstract] [Full Text] [Related]

  • 4. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae.
    Palmqvist P, Persson E, Conaway HH, Lerner UH.
    J Immunol; 2002 Sep 15; 169(6):3353-62. PubMed ID: 12218157
    [Abstract] [Full Text] [Related]

  • 5. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K, Tanabe N, Suzuki N, Kawato T, Takeichi O, Tsuzukibashi O, Makimura M, Ito K, Maeno M.
    Life Sci; 2007 Mar 13; 80(14):1311-8. PubMed ID: 17306833
    [Abstract] [Full Text] [Related]

  • 6. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P, Tu Q, Chen J.
    J Bone Miner Res; 2005 Sep 13; 20(9):1669-79. PubMed ID: 16059638
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the bone-resorptive effect of interleukin-11 in cultured mouse calvarial bones.
    Ahlen J, Andersson S, Mukohyama H, Roth C, Bäckman A, Conaway HH, Lerner UH.
    Bone; 2002 Jul 13; 31(1):242-51. PubMed ID: 12110441
    [Abstract] [Full Text] [Related]

  • 8. Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts.
    Takami M, Takahashi N, Udagawa N, Miyaura C, Suda K, Woo JT, Martin TJ, Nagai K, Suda T.
    Endocrinology; 2000 Dec 13; 141(12):4711-9. PubMed ID: 11108286
    [Abstract] [Full Text] [Related]

  • 9. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R, Morko J, Alatalo SL, NicAmhlaoibh R, Risteli J, Laitala-Leinonen T, Vuorio E.
    Bone; 2005 Jan 13; 36(1):159-72. PubMed ID: 15664014
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway.
    Lerner UH.
    J Bone Miner Res; 1996 Nov 13; 11(11):1628-39. PubMed ID: 8915770
    [Abstract] [Full Text] [Related]

  • 11. Effects on osteoclast and osteoblast activities in cultured mouse calvarial bones by synovial fluids from patients with a loose joint prosthesis and from osteoarthritis patients.
    Andersson MK, Lundberg P, Ohlin A, Perry MJ, Lie A, Stark A, Lerner UH.
    Arthritis Res Ther; 2007 Nov 13; 9(1):R18. PubMed ID: 17316439
    [Abstract] [Full Text] [Related]

  • 12. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.
    Lee SK, Lorenzo JA.
    Endocrinology; 1999 Aug 13; 140(8):3552-61. PubMed ID: 10433211
    [Abstract] [Full Text] [Related]

  • 13. Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K.
    Mandelin J, Li TF, Hukkanen M, Liljeström M, Salo J, Santavirta S, Konttinen YT.
    J Rheumatol; 2005 Apr 13; 32(4):713-20. PubMed ID: 15801030
    [Abstract] [Full Text] [Related]

  • 14. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
    Udagawa N, Takahashi N, Yasuda H, Mizuno A, Itoh K, Ueno Y, Shinki T, Gillespie MT, Martin TJ, Higashio K, Suda T.
    Endocrinology; 2000 Sep 13; 141(9):3478-84. PubMed ID: 10965921
    [Abstract] [Full Text] [Related]

  • 15. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.
    Ishida M, Amano S.
    J Bone Miner Metab; 2004 Sep 13; 22(5):415-29. PubMed ID: 15316862
    [Abstract] [Full Text] [Related]

  • 16. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ.
    J Bone Miner Res; 2000 Aug 13; 15(8):1459-66. PubMed ID: 10934644
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression.
    Kim YH, Kim GS, Jeong-Hwa B.
    Exp Mol Med; 2002 May 31; 34(2):145-51. PubMed ID: 12085990
    [Abstract] [Full Text] [Related]

  • 18. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
    Ikeda T, Utsuyama M, Hirokawa K.
    J Bone Miner Res; 2001 Aug 31; 16(8):1416-25. PubMed ID: 11499864
    [Abstract] [Full Text] [Related]

  • 19. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
    Stilgren LS, Rettmer E, Eriksen EF, Hegedüs L, Beck-Nielsen H, Abrahamsen B.
    Bone; 2004 Jul 31; 35(1):256-65. PubMed ID: 15207766
    [Abstract] [Full Text] [Related]

  • 20. Osteoprotegerin ligand regulates osteoclast adherence to the bone surface in mouse calvaria.
    O'Brien EA, Williams JH, Marshall MJ.
    Biochem Biophys Res Commun; 2000 Aug 02; 274(2):281-90. PubMed ID: 10913332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.